CSS
WVE icon

Cubist Systematic Strategies’s Wave Life Sciences WVE Stock Holding History

Cubist Systematic Strategies’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-163,196
Closed -$1.34M – 3635
2024
Q3 		$1.34M Buy
+163,196
New +$976K 0.01% 1654
2024
Q2 		– Sell
-68,538
Closed -$423K – 4150
2024
Q1 		$423K Buy
68,538
+68,288
+27,315% +$342K ﹤0.01% 2709
2023
Q4 		$1.26K Buy
+250
New +$1.34K ﹤0.01% 3469
2023
Q2 		– Sell
-71,489
Closed -$310K – 4383
2023
Q1 		$310K Sell
71,489
-30,664
-30% -$140K ﹤0.01% 2973
2022
Q4 		$715K Buy
102,153
+95,933
+1,542% +$442K ﹤0.01% 2737
2022
Q3 		$22K Sell
6,220
-14,246
-70% -$47.2K ﹤0.01% 4231
2022
Q2 		$67K Buy
+20,466
New +$39.4K ﹤0.01% 4048
2022
Q1 		– Sell
-11,264
Closed -$35K – 3800
2021
Q4 		$35K Sell
11,264
-5,638
-33% -$23.4K ﹤0.01% 3347
2021
Q3 		$83K Buy
16,902
+3,352
+25% +$20.3K ﹤0.01% 2776
2021
Q2 		$90K Sell
13,550
-61,867
-82% -$404K ﹤0.01% 2722
2021
Q1 		$423K Buy
75,417
+50,910
+208% +$489K 0.01% 2052
2020
Q4 		$193K Sell
24,507
-9,777
-29% -$82.1K ﹤0.01% 2252
2020
Q3 		$291K Buy
34,284
+16,638
+94% +$182K ﹤0.01% 1999
2020
Q2 		$184K Buy
+17,646
New +$166K ﹤0.01% 2062
2020
Q1 		– Sell
-7,422
Closed -$59K – 2496
2019
Q4 		$59K Buy
7,422
+5,022
+209% +$123K ﹤0.01% 2265
2019
Q3 		$49K Buy
2,400
+600
+33% +$13.8K ﹤0.01% 2044
2019
Q2 		$47K Sell
1,800
-19,477
-92% -$546K ﹤0.01% 2331
2019
Q1 		$827K Buy
21,277
+21,155
+17,340% +$858K 0.03% 860
2018
Q4 		$5K Sell
122
-749
-86% -$33.3K ﹤0.01% 1999
2018
Q3 		$44K Buy
+871
New +$39.3K ﹤0.01% 1726
2018
Q1 		– Sell
-200
Closed -$7K – 2106
2017
Q4 		$7K Buy
+200
New +$5.83K ﹤0.01% 1859

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cubist Systematic Strategies's WVE Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Wave Life Sciences (WVE) in Q4 2024, closing a stake of 163,196 shares — an estimated $1.34M sold.

Cubist Systematic Strategies first reported a position in WVE in Q4 2017 and held it in 21 quarters. The position peaked at $1.34M in Q3 2024. 183 funds tracked by Wall St. Rank hold WVE as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Wave Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 163,196 Wave Life Sciences shares in Q4 2024, an estimated $1.34M.
  • Cubist Systematic Strategies first reported a position in Wave Life Sciences in Q4 2017 and held it in 21 quarters.
  • Cubist Systematic Strategies's Wave Life Sciences position peaked at $1.34M in Q3 2024.
  • 183 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.